References
| Author (yr) | Title | Citation | Isolate |
|---|---|---|---|
| Eshleman (2001) | Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). | J Infect Dis | PR HIV1 group M: 229 RT HIV1 group M: 229 |
